JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Compare Rheumatoid Arthritis medicines

Compare Rheumatoid Arthritis medicines

Idacio (adalimumab-aacf) vs Ilaris (canakinumab)

Idacio (adalimumab-aacf) vs Nanozora (ozoralizumab)

Idacio (adalimumab-aacf) vs Simlandi (adalimumab-ryvk)

Idacio (adalimumab-aacf) vs Tofidence (tocilizumab-bavi)

Ilaris (canakinumab) vs Simlandi (adalimumab-ryvk)

Jyseleca (filgotinib) vs Idacio (adalimumab-aacf)

Jyseleca (filgotinib) vs Ilaris (canakinumab)

Jyseleca (filgotinib) vs Nanozora (ozoralizumab)

Jyseleca (filgotinib) vs Rinvoq (upadacitinib)

Jyseleca (filgotinib) vs Simlandi (adalimumab-ryvk)

Jyseleca (filgotinib) vs Tofidence (tocilizumab-bavi)

Jyseleca (filgotinib) vs Yuflyma (adalimumab-aaty)

Kevzara (sarilumab) vs Idacio (adalimumab-aacf)

Kevzara (sarilumab) vs Ilaris (canakinumab)

Kevzara (sarilumab) vs Jyseleca (filgotinib)

Kevzara (sarilumab) vs Nanozora (ozoralizumab)

Kevzara (sarilumab) vs Rinvoq (upadacitinib)

Kevzara (sarilumab) vs Simlandi (adalimumab-ryvk)

Kevzara (sarilumab) vs Tofidence (tocilizumab-bavi)

Kevzara (sarilumab) vs Truxima (rituximab)

Kevzara (sarilumab) vs Yuflyma (adalimumab-aaty)

Nanozora (ozoralizumab) vs Ilaris (canakinumab)

Nanozora (ozoralizumab) vs Simlandi (adalimumab-ryvk)

Nanozora (ozoralizumab) vs Tofidence (tocilizumab-bavi)

Olumiant (baricitinib) vs Idacio (adalimumab-aacf)

Olumiant (baricitinib) vs Ilaris (canakinumab)

Olumiant (baricitinib) vs Jyseleca (filgotinib)

Olumiant (baricitinib) vs Kevzara (sarilumab)

Olumiant (baricitinib) vs Nanozora (ozoralizumab)

Olumiant (baricitinib) vs Rinvoq (upadacitinib)

Olumiant (baricitinib) vs Simlandi (adalimumab-ryvk)

Olumiant (baricitinib) vs Tofidence (tocilizumab-bavi)

Olumiant (baricitinib) vs Truxima (rituximab)

Olumiant (baricitinib) vs Yuflyma (adalimumab-aaty)

Rinvoq (upadacitinib) vs Idacio (adalimumab-aacf)

Rinvoq (upadacitinib) vs Ilaris (canakinumab)

Rinvoq (upadacitinib) vs Nanozora (ozoralizumab)

Rinvoq (upadacitinib) vs Simlandi (adalimumab-ryvk)

Rinvoq (upadacitinib) vs Tofidence (tocilizumab-bavi)

Rinvoq (upadacitinib) vs Yuflyma (adalimumab-aaty)

Tofidence (tocilizumab-bavi) vs Ilaris (canakinumab)

Tofidence (tocilizumab-bavi) vs Simlandi (adalimumab-ryvk)

Truxima (rituximab) vs Idacio (adalimumab-aacf)

Truxima (rituximab) vs Ilaris (canakinumab)

Truxima (rituximab) vs Jyseleca (filgotinib)

Truxima (rituximab) vs Nanozora (ozoralizumab)

Truxima (rituximab) vs Rinvoq (upadacitinib)

Truxima (rituximab) vs Simlandi (adalimumab-ryvk)

Truxima (rituximab) vs Tofidence (tocilizumab-bavi)

Truxima (rituximab) vs Yuflyma (adalimumab-aaty)

Xeljanz (tofacitinib) vs Idacio (adalimumab-aacf)

Xeljanz (tofacitinib) vs Ilaris (canakinumab)

Xeljanz (tofacitinib) vs Jyseleca (filgotinib)

Xeljanz (tofacitinib) vs Kevzara (sarilumab)

Xeljanz (tofacitinib) vs Nanozora (ozoralizumab)

Xeljanz (tofacitinib) vs Olumiant (baricitinib)

Xeljanz (tofacitinib) vs Rinvoq (upadacitinib)

Xeljanz (tofacitinib) vs Simlandi (adalimumab-ryvk)

Xeljanz (tofacitinib) vs Tofidence (tocilizumab-bavi)

Xeljanz (tofacitinib) vs Truxima (rituximab)

Xeljanz (tofacitinib) vs Yuflyma (adalimumab-aaty)

Yuflyma (adalimumab-aaty) vs Idacio (adalimumab-aacf)

Yuflyma (adalimumab-aaty) vs Ilaris (canakinumab)

Yuflyma (adalimumab-aaty) vs Nanozora (ozoralizumab)

Yuflyma (adalimumab-aaty) vs Simlandi (adalimumab-ryvk)

Yuflyma (adalimumab-aaty) vs Tofidence (tocilizumab-bavi)

FR 0